The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison-Reference-Cited by-同舟云学术

The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison

Published:2017-07-18 Issue:7-8 Volume:18 Page:569-575
ISSN:2167-8421
Container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
language:en
Short-container-title:Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Author:

Martin Sarah¹^ORCID,Trevor-Jones Emma¹,Khan Sabyha¹,Shaw Keelan¹,Marchment Deepti¹,Kulka Anna¹,Ellis Catherine E¹,Burman Rachel¹,Turner Martin R.²^ORCID,Carroll Liam³,Mursaleen Leah³,Leigh P. Nigel³,Shaw Christopher E.¹,Pearce Neil⁴,Stahl Daniel¹,Al-Chalabi Ammar¹^ORCID

Affiliation:

1. Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, UK,

2. Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK,

3. Trafford Centre for Biomedical Research, Brighton and Sussex Medical School, Falmer, UK, and

4. Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK

Funder

National Institute for Health Research

Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London

Motor Neurone Disease Association

NIHR Collaboration for Leadership in Applied Health Research and Care South London at King’s College Hospital NHS Foundation Trust

NIHR Collaboration for Leadership in Applied Health Research and Care South London

Publisher

Informa UK Limited

Subject

Clinical Neurology,Neurology

Link

https://tandfonline.com/doi/pdf/10.1080/21678421.2017.1349151

Reference24 articles.

1. Prognostic factors in ALS: A critical review

2. Motor neuron disease: THE BARE ESSENTIALS

3. A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis

4. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

5. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of SARS‐CoV‐2 infection and COVID‐19 pandemic on the morbidity and mortality of amyotrophic lateral sclerosis patients in Valencia, Spain;European Journal of Neurology;2024-09-06

2. Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis – protocol of a German multicentre study;Neurological Research and Practice;2024-07-04

3. Multidisciplinary management and care in rare neuromuscular disorders: A call for action;European Journal of Neurology;2024-02-29

4. Specialized multidisciplinary care improves ALS survival in Belgium: a population-based retrospective study;Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration;2024-01-19

5. Multidisciplinary Clinics in Neuromuscular Medicine;CONTINUUM: Lifelong Learning in Neurology;2023-10